Triple
T789408
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | National Center for Advancing Translational Sciences |
E16877
|
entity |
| Predicate | hasPart |
P35
|
FINISHED |
| Object |
Office of Rare Diseases Research
The Office of Rare Diseases Research is a U.S. government program that coordinates and supports research, information, and collaboration efforts focused on rare diseases.
|
E93883
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Office of Rare Diseases Research | Statement: [National Center for Advancing Translational Sciences, hasPart, Office of Rare Diseases Research]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Office of Rare Diseases Research Context triple: [National Center for Advancing Translational Sciences, hasPart, Office of Rare Diseases Research]
-
A.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
B.
National Institute of Child Health and Human Development
The National Institute of Child Health and Human Development is a U.S. federal biomedical research institute that focuses on understanding human development, improving reproductive health, and enhancing the lives of children and families.
-
C.
National Human Genome Research Institute
The National Human Genome Research Institute is a U.S. government biomedical research organization that leads and funds research on the structure, function, and impact of the human genome.
-
D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
The National Institute of Arthritis and Musculoskeletal and Skin Diseases is a U.S. government biomedical research institute that conducts and supports research on arthritis, musculoskeletal disorders, and skin diseases.
-
E.
National Institute of General Medical Sciences
The National Institute of General Medical Sciences is a U.S. government biomedical research institute that supports fundamental, non-disease-specific science and training to advance understanding of biological processes and lay the groundwork for medical advances.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Office of Rare Diseases Research Triple: [National Center for Advancing Translational Sciences, hasPart, Office of Rare Diseases Research]
Generated description
The Office of Rare Diseases Research is a U.S. government program that coordinates and supports research, information, and collaboration efforts focused on rare diseases.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Office of Rare Diseases Research Target entity description: The Office of Rare Diseases Research is a U.S. government program that coordinates and supports research, information, and collaboration efforts focused on rare diseases.
-
A.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
B.
National Institute of Child Health and Human Development
The National Institute of Child Health and Human Development is a U.S. federal biomedical research institute that focuses on understanding human development, improving reproductive health, and enhancing the lives of children and families.
-
C.
National Human Genome Research Institute
The National Human Genome Research Institute is a U.S. government biomedical research organization that leads and funds research on the structure, function, and impact of the human genome.
-
D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
The National Institute of Arthritis and Musculoskeletal and Skin Diseases is a U.S. government biomedical research institute that conducts and supports research on arthritis, musculoskeletal disorders, and skin diseases.
-
E.
National Institute of General Medical Sciences
The National Institute of General Medical Sciences is a U.S. government biomedical research institute that supports fundamental, non-disease-specific science and training to advance understanding of biological processes and lay the groundwork for medical advances.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a4936cb7448190914f5fe4b8d81607 |
completed | March 1, 2026, 7:28 p.m. |
| NER | Named-entity recognition | batch_69a4a7841b0c8190859ecd247e32c6ec |
completed | March 1, 2026, 8:54 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a6787eac608190acc40d56f827284e |
completed | March 3, 2026, 5:58 a.m. |
| NEDg | Description generation | batch_69a67a663f6c819084b5dffdde3531aa |
completed | March 3, 2026, 6:06 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69a67b1d50b0819088232ad797babced |
completed | March 3, 2026, 6:09 a.m. |
Created at: March 1, 2026, 7:38 p.m.